NCT02177422View on ClinicalTrials.gov

Efficacy and Safety of Chronic Administration of Telmisartan as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate Hypertension

PHASE3CompletedINTERVENTIONAL

Enrollment

489

Participants

Timeline

Start Date

June 30, 1998

Primary Completion Date

November 30, 1999

Conditions

Hypertension

Interventions

DRUG

Telmisartan

telmisartan 80 mg once daily

DRUG

Hydrochlorothiazide

12.5 mg or 25 mg Hydrochlorothiazide in addition to telmisartan in case that the goal response (mean sitting diastolic blood pressure \< 90 mmHg) is not met after at least 4 weeks of treatment with telmisartan